News

20 January 2020
  • Medicina Translacional

Avatar worms help to identify factors that modify genetic diseases

IDIBELL researchers have used gene-editing technology in C. elegans to reproduce human mutations that cause retinitis pigmentaria. With this method, they have studied factors that affect disease development and possible drug treatments.

 

16 January 2020
  • Comunicació i cultura científica
  • Càncer
  • Medicina Regenerativa
  • Neurociències
  • Medicina Translacional

3rd SLHAM of women scientists of IDIBELL arrives

The 3rd SLHAM of women scientists will take place on Saturday, February 8 at 7 pm at the Auditori Barradas, in L'Hospitalet. Nine women researchers and professionals from the Bellvitge Biomedical Research Institute (IDIBELL) will participate.

09 January 2020

Dr Fernando Fernández Aranda, Dr Xavier Bosch, Dr Josep Alfons Espinàs

  • Càncer
  • Neurociències

Three IDIBELL researchers receive funding from the EU H2020 program

Three IDIBELL researchers have received funding from the European Union to develop research projects within the framework of the Work Program on Health of Social Challenges, in the context of the Horizon 2020 research and innovation program, in its 2019 call.

23 December 2019
  • Comunicació i cultura científica

The Christmas concert of L'Hospitalet and IDIBELL closes the first edition of the campaign Save lives and the 15th anniversary of the Institute

On December 20th, the Joventut Theater hosted the extraordinary Christmas concert of L'Hospitalet and IDIBELL, starring this year by the Vallès Symphony Orchestra.

18 December 2019

Gabriel Capellá takes stock of the year in the IDIBELL transparency session

IDIBELL has held its annual transparency session, by the director of the institution, Dr. Gabriel Capellá.